31.9 F
New York
Friday, December 2, 2022

Date:

Share:

Novugen Pharma Became the First Pharmaceutical Company in Malaysia to Receive USFDA Approval for Its Manufacturing Facility

Related Articles

Ramsey Asmar, MD Joins New York Cancer & Blood Specialists

Brooklyn, NY, December 01, 2022 --(PR.com)-- New York Cancer & Blood Specialists (NYCBS), one of the nation’s leading oncology practices, is proud to announce the...

UserWise, LLC Launches Its First eLearning Catalog

San Jose, CA, December 01, 2022 --(PR.com)-- UserWise, LLC, a San Jose, California-based Human Factors consultancy for medical products, has launched its first catalog of...
Bandar Enstek, Malaysia, November 22, 2022 –(PR.com)– Southeast Asia’s first vertically integrated pharmaceutical company, Novugen Pharma Sdn. Bhd., received U.S. Food and Drug Administration (USFDA) approval for its general pharmaceutical manufacturing facility in Bandar Enstek, Negeri Sembilan, Malaysia. This accreditation marks the country’s first pharmaceutical company to receive an approval from the federal agency and the only in Southeast Asia.

This approval will allow Novugen Pharma to export solid oral formulations to the US market from its state-of-the-art manufacturing facility. Novugen Pharma’s manufacturing facility started its site construction in 2017 and was audited by Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) in 2020 after which received the manufacturing license approval from NPRA in the same year. The Company’s product filing for the US started in April 2022 from its facility in Malaysia…

Read more…

Popular Articles